LB Pharmaceuticals Inc Common Stock

NASDAQ:LBRX

Biotechnology

Healthcare
$40.06 -1.30%

-$0.39 today

Market cap
$1.30B
Beta
0.71
P/E (TTM)
-21.4
EPS (TTM)
-$1.39
52W Low $13.36High $33.47

Volume 0.36M

Average 0.23M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$30.40M

FY 2025 · Annual

Net Income

-$25.20M

FY 2025 · Annual

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000
Cost of Revenue0000
Gross Profit0000
Gross Margin————
Research & Development1.35M7.85M51.17M16.74M
Selling, General & Admin1.46M3.53M13.66M13.66M
Operating Expenses2.81M11.38M64.83M30.4M
Depreciation & Amortization2K4K91K321K
EBITDA(12.19M)(1.45M)(63.01M)(24.88M)
EBITDA Margin————
Operating Income(2.81M)(11.38M)(64.83M)(30.4M)
Operating Margin————
Interest Income73K811K1.72M3.92M
Interest Expense2.15M4.83M00
Other Income / Expenses(11.54M)5.1M1.73M5.2M
Income Before Tax(14.35M)(6.27M)(63.1M)(25.2M)
Pre-Tax Margin————
Income Tax Expense1K1K1K1K
Net Income(14.35M)(6.28M)(63.1M)(25.21M)
Net Margin————
EPS (Basic)(4.05)(1.77)(17.83)(1.00)
EPS (Diluted)(4.05)(1.77)(17.83)(1.00)
Weighted Avg Shares3.54M3.54M3.54M25.3M
Weighted Avg Shares (Diluted)3.54M3.54M3.54M25.3M

LBRX Earnings Waterfall · TTM

NASDAQ:LBRX · Revenue to Net Income

Key Ratios

EPS$-21.47
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-12.4
P/S Ratio0.0

Analysis

$0 of revenue converted into -$39.2M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-21.47, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 13, 2026
SC 13G/ASC 13G/A filingOct 13, 2026
4Statement of changes in beneficial ownershipOct 13, 2026

How much revenue does LBRX generate?

LB Pharmaceuticals Inc Common Stock (LBRX) reported $0.00 of revenue in fiscal 2025.

Is LBRX profitable?

LB Pharmaceuticals Inc Common Stock (LBRX) reported -$25.20M of net income.